| NCT Number | NCT07663279 |
| Lead Sponsor | Elisabethinen Hospital |
| Conditions | End Stage Renal Disease |
| Enrollment | 91 participants |
| Start Date | 2026-10 |
| Primary Completion | 2029-10 (estimated) |
| Study Completion | 2029-12 (estimated) |
| Updated on ClinicalTrials.gov | 2026-06-23 |